1. Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site
    Heather M. McGee et al, 2018, International Journal of Radiation Oncology*Biology*Physics CrossRef
  2. Circulating CD16+CD56+ nature killer cells indicate the prognosis of colorectal cancer after initial chemotherapy
    Feng Cui et al, 2019, Medical Oncology CrossRef
  3. Varied functions of immune checkpoints during cancer metastasis
    Ali Safarzadeh et al, 2021, Cancer Immunology, Immunotherapy CrossRef
  4. Circulating NKp46+Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer
    Emilie Picard et al, 2019, OncoImmunology CrossRef
  5. The Role of Circulating CD16+CD56+ Natural Killer Cells in the Screening, Diagnosis, and Staging of Colorectal Cancer before Initial Treatment
    Feng Cui et al, 2019, Disease Markers CrossRef
  6. Systematic Construction and Validation of a Novel Macrophage Differentiation–Associated Prognostic Model for Clear Cell Renal Cell Carcinoma
    Chen Liu et al, 2022, Frontiers in Genetics CrossRef
  7. Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
    Yuqing Cao et al, 2020, Signal Transduction and Targeted Therapy CrossRef
  8. Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer
    Sara SF Al‐Badran et al, 2021, The Journal of Pathology: Clinical Research CrossRef
  9. (Im)maturity in Tumor Ecosystem
    Keywan Mortezaee et al, 2022, Frontiers in Oncology CrossRef
  10. Immune Checkpoints and Innate Lymphoid Cells—New Avenues for Cancer Immunotherapy
    Nicolas Jacquelot et al, 2021, Cancers CrossRef
  11. Checkpoint molecules on infiltrating immune cells in colorectal tumor microenvironment
    Iman M. Talaat et al, 2022, Frontiers in Medicine CrossRef
  12. Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?
    Aviad Ben-Shmuel et al, 2020, Frontiers in Immunology CrossRef
  13. The frequency of Tim-3 on circulating Tfh cells was increased in type 2 diabetes mellitus patients
    Shuai Guo et al, 2020, European Journal of Inflammation CrossRef
  14. Phenotypic and functional exhaustion of circulating CD3+CD56+NKT‐like cells in colorectal cancer patients
    Kangli Cao et al, 2024, The FASEB Journal CrossRef
  15. Dynamics of Peripheral Blood Immune Cells during the Perioperative Period after Digestive System Resections: A Systematic Analysis of the Literature
    Markus Bo Schoenberg et al, 2023, Journal of Clinical Medicine CrossRef
  16. Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer
    François Audenet et al, 2018, World Journal of Urology CrossRef
  17. TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy
    Adam S. Dayoub et al, 2020, Cell Communication and Signaling CrossRef
  18. A systematic scoping review on natural killer cell function in colorectal cancer
    Fiona S. W. Reid et al, 2021, Cancer Immunology, Immunotherapy CrossRef
  19. New avenues for melanoma immunotherapy: Natural Killer cells?
    Costanza Maria Cristiani et al, 2020, Scandinavian Journal of Immunology CrossRef
  20. Functional variants of TIM-3/HAVCR2 3′UTR in lymphoblastoid cell lines
    Feifei Pu et al, 2018, Future Science OA CrossRef
  21. Comparative analysis of immune function, hemorheological alterations and prognosis in colorectal cancer patients with different traditional Chinese medicine syndromes
    Cheng-Yang Wang et al, 2018, Cancer Biomarkers CrossRef